Use of Nicotine Pouches Among Daily Smokers
Milton S. Hershey Medical Center · with National Institute on Drug Abuse (NIDA) · NCT06043362
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 375
- US sites recruiting
- 2
- Study start
- September 17, 2024
- Record last updated
- October 20, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this clinical trial is to understand the health effects of a new oral nicotine pouch, and also to understand if this product can help reduce traditional cigarette smoking. The main aims are:
- Understand the impact of nicotine pouch use on toxicant exposure biomarkers, and indicators of potential harms to health.
- Examine the influence of nicotine pouch use on conventional tobacco product use (cigarettes).
Participants will be randomized to one of six nicotine pouch groups (3 nicotine strengths, each with 2 potential flavors) to use over 16 weeks and asked to reduce their cigarette smoking over that time by at least 75% by substituting with the use of the nicotine pouches. Researchers will compare the outcomes of the different nicotine pouch strengths and flavors to each other. Participants will be asked to complete study questionnaires and provide urine, exhaled carbon monoxide, and mouth cell samples, and other health measurements.
Being studied: 0 mg nicotine pouch; 3 mg nicotine pouch; 6 mg nicotine pouch; Smooth nicotine pouch; Wintergreen nicotine pouch
Conditions: Tobacco Dependence
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Commonly smoke ≥ 5 cigarettes per day (at least 2 days/week) for at least the prior 12 months
- Exhaled CO measurement of ≥ 6 parts per million at baseline
- Must be interested in reducing cigarette consumption by at least 50% and willing to try nicotine pouches
- Able to understand, read and write in English
- Access to e-mail and a smartphone/computer that has reliable internet connection
- Able to understand and give informed consent
Exclusion Criteria
- Plans to quit smoking within the next 30 days
- Currently pregnant, breastfeeding, or planning to become pregnant in the next 6 months
- Recent (past 3 months) unstable illness that may increase risks of participation or ability to participate fully (e.g. hospitalization for a mental health condition or substance use disorder in prior 6 months, stroke or myocardial infarction in the past year)
- Serious current respiratory diseases (e.g. exacerbations of asthma or chronic obstructive pulmonary disease [COPD], requiring oxygen or oral prednisone), kidney disease (e.g. requiring dialysis), liver disease (e.g cirrhosis), or any medical disorder/medication that may affect participant safety or biomarker data
- Use of a nicotine pouch or other non-cigarette nicotine product (e-cigarette, pipe, cigar, chew, snus, hookah, IQOS) for 5 or more days in the past 28 days
- Use of illegal drugs daily or weekly in the past 3 months
- Use of combustible (smoked) recreational or medical marijuana weekly in the past 3 months (less frequent smoked medical marijuana or use of other forms of medical marijuana are ok)
- Other member of the household currently participating in the study
- Any other condition that in the opinion of the investigator would make it unlikely that the participant could comply with the study protocol
Recruiting US locations
Penn State College of Medicine
Hershey, PA 17033
Site contact: Nicolle M Krebs, MS · 717-531-5673 · nkrebs@pennstatehealth.psu.edu
University of Texas MD Anderson Cancer Center
Houston, TX 77030
Site contact: Jason Robinson, PhD · 713-745-3581 · jdrobinson@mdanderson.org
Study contacts (from the official record)
- Nicolle M Krebs, MS · 717-531-5673 · nkrebs@pennstatehealth.psu.edu
- Jonathan Foulds, PhD · 717-531-3504 · jfoulds@pennstatehealth.psu.edu
Similar studies in Pennsylvania
All smoking & vaping studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1
Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18–45
- RecruitingHealthy volunteers
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
RAI Services Company
- Location
- Philadelphia, PA + 6 other US sites
- Eligibility basics
- Ages 21–65
- RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Axsome Therapeutics, Inc.
- Location
- Duncansville, PA + 24 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
Testing ANSOS for Efficacy in Multi-Tribal Urban Communities
Lehigh University
- Location
- Bethlehem, PA
- Eligibility basics
- Ages 18+